SunLink Health Systems, Inc. (NYSEAMERICAN:SSY) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 69,400 shares, a decrease of 27.4% from the March 31st total of 95,600 shares. Based on an average trading volume of 3,800,000 shares, the short-interest ratio is presently 0.0 days. Currently, 1.6% of the company’s shares are short sold.
In other news, Director Christopher H. B. Mills sold 44,308 shares of the firm’s stock in a transaction on Thursday, February 18th. The stock was sold at an average price of $2.33, for a total transaction of $103,237.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Christopher H. B. Mills sold 500,000 shares of the firm’s stock in a transaction on Monday, February 22nd. The stock was sold at an average price of $2.93, for a total value of $1,465,000.00. The disclosure for this sale can be found here. Corporate insiders own 44.50% of the company’s stock.
An institutional investor recently raised its position in SunLink Health Systems stock. Renaissance Technologies LLC lifted its stake in SunLink Health Systems, Inc. (NYSEAMERICAN:SSY) by 22.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 322,245 shares of the company’s stock after purchasing an additional 58,500 shares during the period. Renaissance Technologies LLC owned about 4.67% of SunLink Health Systems worth $409,000 at the end of the most recent quarter. 15.04% of the stock is owned by institutional investors.
Separately, TheStreet upgraded SunLink Health Systems from a “d+” rating to a “c” rating in a research report on Wednesday, February 17th.
NYSEAMERICAN:SSY traded down $0.37 during midday trading on Tuesday, reaching $2.87. The company had a trading volume of 50,106 shares, compared to its average volume of 3,391,553. The firm has a market cap of $19.80 million, a price-to-earnings ratio of -16.72 and a beta of 1.33. The business’s fifty day simple moving average is $1.17. SunLink Health Systems has a 12-month low of $0.76 and a 12-month high of $7.62. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.66 and a quick ratio of 1.49.
SunLink Health Systems (NYSEAMERICAN:SSY) last released its earnings results on Tuesday, February 16th. The company reported $0.46 earnings per share (EPS) for the quarter. The firm had revenue of $10.15 million during the quarter. SunLink Health Systems had a negative return on equity of 4.31% and a negative net margin of 2.62%.
SunLink Health Systems Company Profile
SunLink Health Systems, Inc, through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit and a 66-bed nursing home in Mississippi; as well as offers information technology services.
Read More: New Google Finance Tool and Screening Stocks
Receive News & Ratings for SunLink Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunLink Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.